(Q41151166)
Statements
A Randomized, Double-Blind, Phase III Study of the Immunogenicity and Safety of a 9-Valent Human Papillomavirus L1 Virus-Like Particle Vaccine (V503) Versus Gardasil® in 9-15-Year-Old Girls (English)
Timo Vesikari
Nicholas Brodszki
Pierre van Damme
Giancarlo Icardi
Clément Tran
Stéphane Thomas
Alain Luxembourg
Martine Baudin
1 September 2015